News
Elanco Animal Health
ELAN · NYSE
$22.70−$0.79 (−3.36%)TodayMarket closed ·
Prev close $23.49
Latest news
- Press releasePRNewswire
Elanco to Participate in BofA Securities Global Healthcare Conference 2026
- Press releasePRNewswire
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
- Press releasePRNewswire
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement
- Press releasePRNewswire
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
- Press releasePRNewswire
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility
- NewsAvi Kapoor
Netflix, Eli Lilly, Elanco Animal Health And More Stock On CNBC’s ‘Final Trades’
- Press releasePRNewswire
Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species
- News
Reported Earlier, FDA Issues Issues Emergency Use Authorization For Elanco's CLiK Extra Wound Spray For Prevention Of New World Screwworm Infestations
- NewsVandana Singh
Elanco Sees Strong Pet Health Momentum, Bets on Innovative Products
- NewsAvi Kapoor
Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday
- Press releasePRNewswire
Elanco Animal Health Reports Second Quarter 2026 Results
- Press releasePRNewswire
Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs
- Press releasePRNewswire
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)
- Press releasePRNewswire
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
- Press releasePRNewswire
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
- Press releasePRNewswire
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
- Press releasePRNewswire
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
- Press releasePRNewswire
New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience
- Press releasePRNewswire
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
- Press releasePRNewswire
Elanco to Participate in Upcoming Investor Conferences
- News
Earnings Scheduled For May 6, 2026
- NewsVandana Singh
Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum
- News
Elanco Animal Health Reports Q1 2026 Results: Full Earnings Call Transcript
- News
Elanco Animal Health Q1 Adj. EPS $0.40 Beats $0.35 Estimate, Sales $1.371B Beat $1.288B Estimate
- Press releasePRNewswire
Elanco Animal Health Reports First Quarter 2026 Results
- Press releasePRNewswire
/C O R R E C T I O N -- Elanco Animal Health/
- Press releasePRNewswire
Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock
- Press releaseBusiness Wire
National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer
- Press releasePRNewswire
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement
- Press releasePRNewswire
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*
- Press releaseGlobe Newswire
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of DICK's Sporting Goods, Inc. (DKS), Domino's Pizza, Inc. (DPZ), Elanco Animal Health Incorporated (ELAN), and Elevance Health, Inc. (ELV)
- NewsPiero Cingari
Trump Slams NATO, Energy Sector Rallies As Fuel Prices Spike: What's Moving Markets Tuesday?
- Press releasePRNewswire
Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results
- Press releasePRNewswire
Elanco Investor Day Defines New Era as Sustainable Growth Company
- NewsAvi Kapoor
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
- Press releasePRNewswire
Elanco Animal Health Reports Third Quarter 2025 Results
- Press releasePRNewswire
Elanco Animal Health Reports Second Quarter 2025 Results
- News
P/E Ratio Insights for Elanco Animal Health
- Press releasePRNewswire
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer
- Press releasePRNewswire
Elanco Animal Health Reports First Quarter 2025 Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.